Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional versus standard COVID-19 vaccine doses in Nigerian adults
PACTR202206754734018Phase 3Completed
- Sponsor
- Federal Ministry of Health
- Start
- May 2022
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Federal Ministry of Health. Started May 2022; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202206754734018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202206754734018.